Clorox or Amcor: Two High Yields, Two Different Balance-Sheet Risks

Clorox and Amcor both offer yields above 5%, yet neither distribution looks comfortable when measured against the latest full-year cash flow.

Clorox generated $405 million of free cash flow in fiscal 2026 and paid $602 million in dividends. That gap is the clearest challenge to the income thesis. Management expects the pressure to ease as investment spending and working capital normalize, while fiscal 2027 guidance calls for 3.5% to 4.5% organic sales growth. Investors still need proof that improved earnings convert into cash.

Amcor's numbers are less visibly uncovered but leave little margin. The packaging company generated about $1.23 billion of free cash flow and paid roughly $1.20 billion of dividends in fiscal 2026, a payout near 97%. Its combination with Berry Global lifted annual sales to about $23.5 billion and adjusted EPS to $4.02, but also left net debt around $12.9 billion. Integration savings could improve coverage; higher financing costs or slower demand could erase it.

The operating exposures differ. Clorox depends on branded consumer products, pricing power and a costly supply-chain transition. Amcor sells packaging across many end markets, which diversifies demand but adds integration complexity and ties the company to industrial volumes.

Neither dividend has much room for a fresh operating setback. Clorox offers more recovery upside if margins and cash conversion rebound. Amcor offers a slightly higher yield and a larger post-merger platform, but its leverage and near-total use of free cash flow make execution central. For income investors, the safer choice is the company that first demonstrates sustained coverage after capital spending, not simply the stock with the larger quoted yield.